RecruitingNot applicableEN originalColorectal cancer

Complete Closure After Endoscopic Mucosal Resection of Large Non-Pedunculated Colorectal Polyps

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

The goal of this clinical trial is to compare adverse even rates after EMR for large (≥20mm) flat colorectal polyps (so-called laterally spreading lesions, LSLs) when performing complete or no defect closure. It will also evaluate lesion recurrence after EMR for large colorectal LSLs. The hypothesis is that performing complete defect closure following EMR of large colorectal LSLs will result in lower rates of adverse events compared to cases where no defect closure is performed. For participants with planned EMR, endoscopists will perform EMRs as per standard of care and: * prophylactic defect closure will either not be performed (control group), or will be performed (experimental group); * then, patients will be called between 14 and 44 days after EMR to assess for possible adverse events, and electronic medical files will be verified for emergency room visits and healthcare received for an adverse event; * finally, patients will undergo follow-up colonoscopy 6 months and 18 months after randomization.

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • Wiek 18 lat lub więcej
  • Zaplanowana operacja usunięcia dużego polipa jelita grubego (co najmniej 20 mm)
  • Wyrażona pisemna zgoda na udział w badaniu

✗ Disqualifies

  • Choroba zapalna jelit
  • Poważne problemy ogólne ze zdrowiem
  • Zaburzenia krzepnięcia krwi lub niedobór płytek krwi
  • Polip na szypule
  • Podejrzenie głębokich zmian nowotworowych
  • Ciąża

Simplified criteria — AI translation

Trial details

Minimum age
18 Years
Last updated (source)
August 11, 2026
Sex
No restrictions

Therapies / drugs in trial

Locations (1)

Centre Hospitalier de l'Université de Montréal

Montreal, Canada

Trial contact

Daniel von Renteln, MD

PRINCIPAL_INVESTIGATOR

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/12/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.